Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Apr 13, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how an artificial intelligence (AI) program can help doctors better understand heart rhythms by analyzing electrocardiograms (ECGs). The goal is to see if the AI can automatically measure important features of the ECG and identify specific heart conditions, like Long QT syndrome, which can lead to dangerous heart rhythms called ventricular arrhythmias. By using this technology, researchers hope to improve the detection of these conditions in patients.
To participate in the trial, you need to be at least 18 years old and have an ECG recommended by your doctor. If you have a pacemaker or any medical reasons that prevent you from having an ECG, you won’t be eligible. If you decide to join, you will help researchers understand if this AI tool can be a useful way to monitor heart health. This trial is currently recruiting participants of all genders, and your involvement could lead to better heart care for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18
- • Patients or subjects taken care in recruiting centres for which an ECG is indicated
- • No opposition to participation in the study
- Exclusion Criteria:
- • Medical contraindication for ECG
- • Subjects with pacemaker-driven QRS
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Joe-Elie SALEM, PU-PH
Principal Investigator
Assistance Publique - Hôpitaux de Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported